Bellus Health Inc

NASDAQ:BLU  
6.25
+0.16 (+2.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)500.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.01 Million
Adjusted EPS-$0.22
See more estimates
10-Day MA$6.10
50-Day MA$5.02
200-Day MA$3.99
See more pivots

Bellus Health Inc Stock, NASDAQ:BLU

275 Armand-Frappier boulevard, Laval, Qu?©bec H7V 4A7
Phone: +1.450.680.4500
Number of Employees:

Description

BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.